Business

Sipcam agreement for Australia and New Zealand

Sipcam agreement for Australia and New Zealand.

articleEden Research PlcOctober 15, 20185/company/eden-research-plc/news/sipcam-agreement-for-australia-and-new-zealand
Sipcam agreement for Australia and New Zealand

About this update from Eden Research Plc

[{"type":"text","content":"\n \nRNS Number : 0069E Eden Research plc 15 October 2018  \n\n \n \n \n15 October 2018\n \nEden Research plc\n \n(\"Eden\" or \"Company\")\n \nExclusive distribution agreement signed for Australia and New Zealand\nEden Research plc (AIM: EDEN), the AIM listed company that develops and supplies breakthrough biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries, announces that it has signed an exclusive distribution agreement (\"Agreement\") with Sipcam SpA (\"Sipcam\") for its fungicide product (the \"Product\") to be sold in Australia and New Zealand.  The Product, which is currently sold in Europe and Africa, will be marketed by Sipcam in Australia and New Zealand under the trade name \"Novellus\" following receipt of the requisite approvals. In conjunction with the distribution agreement, the application for the registration of Novellus has been submitted to the Australian regulatory authorities and the process is anticipated to be completed in time for the 2020 growing season.\nThe Agreement allows Sipcam to sell Novellus in Australia and New Zealand on an exclusive basis, primarily for the treatment of botrytis on grapes. Botrytis is a fungus that affects many plant species, but it is particularly problematic for grape growers due to the rapid progression of the disease and its significant impact on crop yield and wine quality.  Sipcam is already the exclusive distributor for the Product in Italy and Spain, and therefore has good product knowledge and insight into the grape fungicide market, making it well-positioned to commercialise the Product in a market with significant potential.\nAustralia and New Zealand are both major producers of grapes and wine, with Australia being included in the world's top ten. The need for an effective product for the treatment of botrytis is well-known in both countries and is even more important after the removal of iprodione for sale in Europe. As much of Australia's wine is exported, the Australian Wine Research Institute (AWRI) has stated that products containing the active constituent iprodione are no longer recommended for use on Australian grapes destined for export.\nSean Smith, Chief Executive Officer of Eden, said: \"There is a clear opportunit...

More updates from Eden Research Plc